Health Care › Biological Products (No Diagnostic Substances)

SRRK Stock Price Correlated With Scholar Rock Holding Financials

SRRK Stock Price vs. Quarterly

Enable JavaScript to see charts like this:

log linear

Income Statement

Cash Flow

Balance Sheet

SRRK Income Statement

Enable JavaScript and reload

Revenue, Net:

Revenue Per Share:

Cost of Goods & Services Sold:

Gross Profit:

Selling, General & Admin Expense:

Research & Development Expense:

Total Operating Expenses:

Operating Income:

Income Taxes:

Net Income:

Earnings Per Share, Diluted:

Earnings Per Share, Basic:

Shares Outstanding, Basic Avg:

Shares Outstanding, Diluted Avg:

Common Stock Shares Outstanding:

SRRK Cash Flow

Enable JavaScript and reload

Operating Activities Net Income:

Depreciation, Depletion & Amortization:

Change in Accounts Receiveable:

Net Cash from Operations:

Net Cash from Operations Per Share:

Repurchases/Buybacks Common Stock:

Issuance of Long-term Debt:

Cash Dividends Paid:

Net Cash from Financing Activities:

Property, Plant & Equipment Purchases:

Purchases of Businesses, Net of Cash:

Net Cash from Investing Activities:

Net Change in Cash & Equivalents:

SRRK Balance Sheet

Enable JavaScript and reload

Cash and Cash Equivalents:

Short-Term Investments:

Accounts Receivable, Net:

Inventories:

Total Current Assets:

Property, Plant & Equipment, Net:

Total Assets:

Accounts Payable:

Current Portion of Long-Term Debt:

Total Short-Term Liabilities:

Long Term Debt, Non-Current Portion:

Total Long-Term Liabilities:

Total Liabilities:

Insider Trading

Change

Value

Transaction

SEC Form 4

Samsara BioCapital GP, LLC 10% Owner

2,189,781 sh at $7

$15,000,000

Buy

2023-10-18

AKKARAJU SRINIVAS Director and 10% Owner

2,189,781 sh at $7

$15,000,000

Buy

2023-10-18

Invus Public Equities, L.P. 10% Owner

2,199,931 sh at $7

$15,086,736

Buy

2023-10-16

Major Holders (from 13F filings)

Investment Type

Change

Value (x$1000)

increase or decrease

Artal Group S.A.

9,059,507 sh

$64,322

FMR

8,005,654 sh

291,156 sh
4%

$56,840

-$1,326

Price T Rowe Associates /Md/

7,171,952 sh

86,849 sh
1%

$50

-$3

Redmile Group

4,733,248 sh

329,408 sh
7%

$33,606

$401

Blackrock.

3,480,645 sh

689,674 sh
25%

$24,713

$3,669

Vanguard Group

2,052,718 sh

67,959 sh
3%

$14,574

-$390

Orbimed Advisors

2,033,789 sh

1,298,144 sh
176%

$14,440

$8,893

Goldman Sachs Group

1,088,074 sh

-302,731 sh
-22%

$7,725

-$2,762

Geode Capital Management

853,072 sh

184,218 sh
28%

$6,057

$1,014

State Street

813,984 sh

39,204 sh
5%

$5,779

-$63

Laurion Capital Management Lp

553,700 sh

15,902 sh
3%

$3,931

-$124

AXA

539,762 sh

48,004 sh
10%

$3,832

$124

Northernrp

409,433 sh

95,676 sh
30%

$2,906

$540

Td Asset Management

336,294 sh

91,371 sh
37%

$2,388

$541

Sectoral Asset Management

310,398 sh

64,663 sh
26%

$2,204

$351

Vontobel Holding.

310,398 sh

64,663 sh
26%

$2,204

$351

Charles Schwab Investment Management

302,384 sh

48,382 sh
19%

$2,147

$232

Dimensional Fund Advisors

291,842 sh

93,235 sh
47%

$2,073

$578

Morgan Stanley

220,556 sh

-26,899 sh
-11%

$1,566

-$300

Ubs Oconnor

212,581 sh

10,000 sh
5%

$1,509

-$18

Free historical financial statements for Scholar Rock Holding Corp. See how revenue, income, cash flow, and balance sheet financials have changed over 19 quarters since 2019. Compare with SRRK stock chart to see long term trends.

Data imported from Scholar Rock Holding Corp SEC filings. Check original filings before making any investment decision.